Replies to post #172982 on Amarin Corp Plc (AMRN)

[couldbebetter]

It all depends on what Big Pharma believes AMRN is worth and what JT
believes he can get. None of us have enough data to make a solid
estimate. One can presume that an interested BP has modeled out peak
sales based on R-I results for those markets they are familiar with.
A reasonable buyout estimate might be within the range of price target
estimates which range from $15-$51. Of course, HDGabor thinks a
bidding war for AMRN could potentially move the price to over $100.
I happen believe that $35-$42 would be a reasonable buyout price range.
Do I believe a takeover at over $100 could be justified? Sure, but
that would mean some BP believes Vascepa would have peak revenues of
over $9 billion a year. To get to that level all it might take is
having 3 million patients using Vascepa in North America and 2 million
patients in Europe. Some would argue those numbers are far to low...
and that is why we really don't know.